Announced Tue, 7 Jul · 16:23 IST
Credit rating upgraded to IND AA- with Stable outlook
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.6%1-day move
₹597.10
prior close
₹599.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+0.4+0.6-0.5+4.6+5.0+5.7+4.4+8.0+3.8————
Up moveDown movePending
AI summary
India Ratings upgraded Shilpa Medicare's bank loan rating to IND AA-/Stable (from A+/Positive), short-term to A1+. Subsidiary Shilpa Pharma Lifesciences also got upgraded on INR 3,000 million facilities, with fresh AA- rating on additional INR 750 million. Old NCDs of INR 750 million were fully repaid and rating withdrawn.
Likely market impact
Stronger credit profile signals improved financial health, potentially lowering borrowing costs. Positive sentiment for shareholders.